SDC1 and prostate cancer: Meanwhile, syndecan-1 expression has been correlated with a lipogenic phenotype in advanced prostate cancer [4,27,28,33,40,41,42,43,44,45] and has been linked to αvβ3 integrin activation in breast cancer [46].